Restoring Vision with a Protein-Based Artificial Retina
LambdaVision is developing the first protein-based artificial retina to restore meaningful vision for patients who are blind or have lost significant sight due to advanced retinal degenerative diseases, including retinitis pigmentosa (RP) and age-related macular degeneration (AMD).
Both RP and AMD lead to the breakdown and loss of cells in the retina. By using proteins similar to the visual pigment rhodopsin that is naturally found in our eyes, LambdaVision’s protein-based artificial retina mimics the light-absorbing properties of human photoreceptors replacing the function of these damaged cells in the retinas of blind patients.
Learn More
In the Media
LambdaVision to Study Light-Activated Proteins on NASA’s Upcoming Flight to International Space Station
Read more...
LambdaVision Secures Further NASA Funding to Utilize Company's Advanced Production Processes for Additional Applications
Read more...
New ISS National Lab Research Aims to Treat Blindness
Power of Possible: LambdaVision Retinal Implant
Inside UConn TIP Podcast Series